Industry Insights
LAMP-based Test Could Enable Point-of-Care COVID-19 Testing
Industry InsightTechnology Networks spoke to Dr Christopher Stanley, CEO of MicrosensDx, to learn more about the RapiPREP® COVID-19 test and the difference point-of-care testing could make to the response to the pandemic.
Read More
Using Bioprinted Tissue Models To Test Drugs Against Diseases Including COVID-19
Industry InsightTechnology Networks recently had the pleasure of speaking with Keith Murphy, CEO and founder of Viscient Biosciences to learn about the company's expertise in 3D disease models and multi-omics drug discovery approaches, and how they are using these techniques to test drugs against SARS-CoV-2 using bioprinted lung tissue.
Read More
Gene Therapy a New Paradigm for Healthcare: An Interview With bluebird bio
Industry Insight Technology Networks recently spoke with Martin Butzal, Head of Medical Europe at bluebird bio, to learn more about the exciting developments and key trends in the gene therapy space.
Making Allogeneic Cell Therapy a Reality for Patients: An Interview With Allogene Therapeutics
Industry InsightTechnology Networks spoke with David Chang, MD, PhD, President, Chief Executive Officer and Co-Founder of Allogene to learn about the recent developments in the fast-developing allogeneic cell therapy research space and Allogene's visions for the future.
Read More
Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry InsightTechnology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.
Read More
Looking to the Future of Cell and Gene Therapies
Industry InsightTechnology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.
Read More
Companion Diagnostic Will Support NSCLC Clinical Trials
Industry InsightTo learn more about some of the ways that companion diagnostics can benefit oncology patients, Technology Networks spoke to Dr Luca Quagliata, Global Director of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific.
Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable
Industry InsightTwo teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.
Using Fast-growing Tobacco Plants To Develop a COVID-19 Vaccine
Industry InsightTechnology Networks recently spoke to David O’Reilly, PhD, Director of Scientific Research at BAT to learn more about the tobacco plant “biomanufacturing factories” that are being used to develop a COVID-19 vaccine. We also discuss the challenges faced when developing a vaccine and the benefits tobacco plants offer compared to conventional vaccine development methods.
Read More
Developing Personalized Strategies To Maximize Cancer Therapy Success
Industry InsightTechnology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.
Read More
